Lv11
30 积分 2023-12-26 加入
NI-3201 Is a Bispecific Antibody Mediating PD-L1–Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor Control
4小时前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
4个月前
已完结
Clinical translation of antibody drug conjugate dosing in solid tumors from preclinical mouse data
5个月前
已完结
The therapeutic window of antibody drug conjugates: A dogma in need of revision
5个月前
已完结
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer
6个月前
已完结
Chromatin remodellers as therapeutic targets
6个月前
已完结
Influence of the dissociation rate constant on the intra-tumor distribution of antibody-drug conjugate against tissue factor
6个月前
已完结
Sequential immunotherapy: towards cures for autoimmunity
6个月前
已完结
The therapeutic window of antibody drug conjugates: A dogma in need of revision
7个月前
已完结
A Novel Approach for Quantifying the Pharmacological Activity of T-Cell Engagers Utilizing In Vitro Time Course Experiments and Streamlined Data Analysis
8个月前
已完结
皖公网安备34019202002308
